B. Riley Wealth Advisors’s Puma Biotechnology PBYI Stock Holding History

B. Riley Wealth Advisors’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,191	Closed	-$2.25M	–	1560
2014 Q4	$2.25M	Buy	+1,191	New	+$264K	0.05%	520
2014 Q3	–	Sell	-5	Closed	-$330	–	1515
2014 Q2	$330	Buy	+5	New	+$356	﹤0.01%	2371

Other funds holding PBYI

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

B. Riley Wealth Advisors's PBYI Position: Q1 2015 in Review

B. Riley Wealth Advisors sold out of Puma Biotechnology (PBYI) in Q1 2015, closing a stake of 1,191 shares — an estimated $2.25M sold.

B. Riley Wealth Advisors first reported a position in PBYI in Q2 2014 and held it in 2 quarters. The position peaked at $2.25M in Q4 2014. 199 funds tracked by Wall St. Rank hold PBYI as of Q1 2015.

B. Riley Wealth Advisors reported no remaining Puma Biotechnology position as of Q1 2015 after selling out during the quarter.
B. Riley Wealth Advisors sold 1,191 Puma Biotechnology shares in Q1 2015, an estimated $2.25M.
B. Riley Wealth Advisors first reported a position in Puma Biotechnology in Q2 2014 and held it in 2 quarters.
B. Riley Wealth Advisors's Puma Biotechnology position peaked at $2.25M in Q4 2014.
199 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2015.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2015, filed 14 May 2015.